Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Summary
The purpose of this study is to determine whether hypofractionated concurrent chemo-radiotherapy has the same efficiency as conventionally fractionated concurrent chemo-radiotherapy in Limited Disease Small Cell Lung Cancer.
Official title: Phase III Randomized Study of Hypofractionated vs Conventionally Fractionated Concurrent Chemo-radiotherapy for Limited Disease Small Cell Lung Cancer
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
860
Start Date
2016-02
Completion Date
2023-12
Last Updated
2026-05-29
Healthy Volunteers
No
Conditions
Interventions
hypofractionated concurrent chemoradiotherapy
For patients with Limited Disease Small Cell Lung Cancer, 45Gy/15F of radiotherapy with concurrent chemotherapy will be used in experimental arm.
conventionally fractionated concurrent chemoradiotherapy
For patients with Limited Disease Small Cell Lung Cancer, 60Gy/30F of radiotherapy with concurrent chemotherapy will be used in the control arm.
Locations (1)
Cancer Insititute and Hosiptal of Chinese Academy of Medical Sciences
Beijing, China